Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Flow cytometry minimal residual disease analysis and reporting in multiple myeloma.|
|Full bibliographic reference||Arroz M, Came N, Lin P, Chen W, Yuan C, Lagoo A, Monreal M, de Tute R, Vergilio JA, Rawstron AC, Paiva B. Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting. Cytometry B Clin Cytom. 2016;90(1):31-39.|
|Study design||Clinical trials, Diagnostic and prognostic studies, Experimental studies|
|Clinical area||Haematology, Oncology|
|Applies to the whole report or to individual sections of the report?||Procedure/Method, Results|
|Record last updated on||March 18, 2016|
|Diagnostic / prognostic studies||STARD||TRIPOD|
|Quality improvement studies||SQUIRE|
|Animal pre-clinical studies||ARRIVE|
|Clinical practice guidelines||AGREE||RIGHT|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.
For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.
Visit our Help page for information about searching for reporting guidelines and for general information about using our website.
Our full catalogue of reporting guidelines is available to download as a PDF: Reporting Guideline Catalogue May 2014.